17:09 EDT Calidi files $25M mixed securities shelf
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CLDI:
- Calidi Biotherapeutics Gains FDA Nod for Brain Cancer Trial
- Calidi announces FDA clearance of Northwestern University’s IND application
- Calidi Biotherapeutics Presents Antitumor Virotherapy Advances
- Calidi price target lowered to $2.50 from $20 at Baird
- Calidi Biotherapeutics Unveils Redtail Biopharma Subsidiary